These companies are on the cutting edge of technology in their respective fields, yet still command attention with their solid earnings and impressive service/product line.

Please keep in mind that you should consult your financial professional prior to implementing any changes within your investment portfolio.

Paul Michael Jenkins is an investment advisor for LOM Holdings Ltd. can be reached at 292-5000 or at paul.jenkinslom.bm

Symbol Exchange

EBAY NASDAQ

52 Wk High: $61.60 52 Wk Low: $32.50

Current Price: $52.65

Ebay is one of the world's largest online trading communities. The company creates a powerful marketplace for the sale of goods and services by a passionate community of individuals and small businesses. Ebay enables trade on a local, national and international basis with local sites in numerous markets in the United States and country-specific sites in the United Kingdom, Canada, Germany, Austria, France, Italy, Japan, Korea and Australia.

On October 16 of this year, Ebay reported net revenues up 84 percent year over year to 530.9 million. Operating income was up 73percent to 155.9 million year over year as well.

Symbol Exchange

RIMM NASDAQ

52 Wk High: $47.90 52 Wk Low: $10.76

Current Price: $45.08

Research In Motion is a designer, manufacturer and marketer of wireless solutions for the mobile communications market. Through development and integration of hardware, software and services, the Company provides solutions for access to information including email, messaging, Internet and intranet-based applications.

Shares of Research In Motion Ltd. have been trading close to year highs as after the company unveiled plans to make its wireless e-mail service available on cellphones and handheld devices other than its own BlackBerrys.

SYMBOL: DNA EXCHANGE: NYSE

52 WK HI: $88.00 52 WK LO: $31.53

Current Price: $83.66

Genentech, the founder of the biotechnology industry, is a company with a quarter-century track record of delivering on the promise of biotechnology. Today, Genentech is among the world's leading biotech companies, with ten protein-based products on the market for serious or life-threatening medical conditions and 20 projects in the pipeline. With its strength in all areas of the drug development process - from research and development to manufacturing and commercialization - Genentech continues to transform the possibilities of biotechnology into improved realities for patients.